Kaeberlein Receives New Scholar Award in Aging

Matt Kaeberlein, Ph.D., Assistant Professor, recently received a New Scholar Award in Aging from the Ellison Medical Foundation.  The award supports a project to follow-up on a paper that Dr. Kaeberlein published in Genome Research earlier this year, which defined 25 genes that function similarly to regulate aging in yeast and worms.  The Kaeberlein Lab is trying to figure out how these conserved aging genes are working at a molecular level and evaluate their potential as drug targets for treating age-associated disorders, such as diabetes and Alzheimer's disease, in people.

The objective of The Ellison Medical Foundation New Scholars Program is to support new investigators of outstanding promise in the basic biological sciences relevant to understanding lifespan development processes and age-related diseases and disabilities. The award is intended to provide significant support to new investigators needed to permit them to become established in the field of aging. The New Scholars Program provides awards of up to $100,000 per year for a four-year period for successful candidates. The Ellison Medical Foundation was established and is supported by Lawrence J. Ellison to support biomedical research (including basic biology, basic biomedicine and epidemiology) on aging.